Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
10 Janeiro 2025 - 11:01AM
Edgar (US Regulatory)
Exhibit 1
Transactions in the Securities of the
Issuer in the Past Sixty Days
| Nature of the Transaction |
Amount of Securities
Purchased/(Sold) |
Price ($) |
Date of
Purchase/Sale |
PHILOTIMO
FUND, LP
| Purchase of Common Stock |
56,910 |
2.8986 |
12/13/2024 |
| Purchase of Common Stock |
5,681 |
2.9991 |
12/16/2024 |
| Purchase of Common Stock |
115,414 |
2.6604 |
12/17/2024 |
| Purchase of Common Stock |
45,455 |
2.5624 |
12/18/2024 |
| Purchase of Common Stock |
42,690 |
2.3914 |
12/19/2024 |
| Purchase of Common Stock |
54,901 |
2.4964 |
12/20/2024 |
| Purchase of Common Stock |
82,043 |
2.3927 |
12/23/2024 |
| Purchase of Common Stock |
92,664 |
2.4215 |
12/24/2024 |
| Purchase of Common Stock |
4,243 |
2.4422 |
12/26/2024 |
PHILOTIMO
FOCUSED GROWTH & INCOME FUND
| Purchase of Common Stock |
56,910 |
2.8986 |
12/13/2024 |
| Purchase of Common Stock |
5,680 |
2.9991 |
12/16/2024 |
| Purchase of Common Stock |
115,414 |
2.6604 |
12/17/2024 |
| Purchase of Common Stock |
45,455 |
2.5624 |
12/18/2024 |
| Purchase of Common Stock |
42,689 |
2.3914 |
12/19/2024 |
| Purchase of Common Stock |
54,901 |
2.4964 |
12/20/2024 |
| Purchase of Common Stock |
82,043 |
2.3927 |
12/23/2024 |
| Purchase of Common Stock |
92,664 |
2.4215 |
12/24/2024 |
| Purchase of Common Stock |
80,683 |
2.4422 |
12/26/2024 |
| Purchase of Common Stock |
44,000 |
2.5100 |
12/26/2024 |
| Purchase of Common Stock |
54,839 |
2.5673 |
12/27/2024 |
| Purchase of Common Stock |
249,733 |
2.7477 |
12/30/2024 |
| Purchase of Common Stock |
238,368 |
2.9846 |
12/31/2024 |
| Purchase of Common Stock |
70,297 |
2.8879 |
01/02/2025 |
| Purchase of Common Stock |
155,279 |
3.0021 |
01/03/2025 |
| Purchase of Common Stock |
111,056 |
2.9827 |
01/06/2025 |
| Purchase of Common Stock |
11,778 |
2.9480 |
01/07/2025 |
| Purchase of Common Stock |
143,222 |
3.0566 |
01/08/2025 |
Exhibit 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree
that the statement on Schedule 13D with respect to the Common Shares, without Par Value, of Quipt Home Medical Corp. dated as of the date
hereof is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant
to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
| Philotimo Fund, LP |
| |
| By: |
/s/ David L. Kanen |
|
| |
David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its general partner |
| Date: |
01/10/2025 |
| Philotimo Focused Growth & Income Fund |
| |
| By: |
/s/ David L. Kanen |
|
| |
David L. Kanen, Managing Member of Kanen Wealth Management, LLC, its investment adviser |
| Date: |
01/10/2025 |
| Kanen Wealth Management LLC |
| |
| By: |
/s/ David L. Kanen |
|
| |
David L. Kanen, Managing Member |
| Date: |
01/10/2025 |
| Kanen David |
| |
| By: |
/s/ David L. Kanen |
|
| |
David L. Kanen |
| Date: |
01/10/2025 |
Quipt Home Medical (NASDAQ:QIPT)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Quipt Home Medical (NASDAQ:QIPT)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
